Exercise remains one of the most effective therapeutic strategies for managing glycemic control in type 2 diabetes. However, data regarding the efficacy of such interventions to reduce vascular comorbidities of diabetes is limited. A better understanding of the effects of exercise and physical activity on the integrated physiological systems that are involved in the pathophysiology of vascular comorbidities may contribute to the foundations of optimal prescriptions. It may also help to determine the mechanisms responsible for such changes. Data which include multiple populations are also a priority in physiological research as there is a disproportionate prevalence of type 2 diabetes morbidity and mortality across several under-represented groups.
The first goal of this research topic is to determine the influence of exercise and/or physical activity on vascular comorbidity development and/or prognosis in type 2 diabetes. Secondly, this research topic aims to seek specific data that focusses on under-represented populations within the medical literature. We are hopeful that the realization of these goals may assist clinical and exercise practitioners when developing exercise interventions for their patients.
Specific themes of interest include but are not limited to:
• Novel exercise strategies for reducing vascular comorbidities of type 2 diabetes
• Sex, race/ethnicity, and age differences in response to exercise in type 2 diabetes
• Barriers to exercise in people with type 2 diabetes and the impact on vascular comorbidities
• Novel clinical approaches to exercise adherence in type 2 diabetes and the impact on vascular comorbidities
• Comparison of moderate intensity aerobic training to other exercise modalities in reducing vascular comorbidities of type 2 diabetes
All articles accepted by Frontiers are encouraged.
Exercise remains one of the most effective therapeutic strategies for managing glycemic control in type 2 diabetes. However, data regarding the efficacy of such interventions to reduce vascular comorbidities of diabetes is limited. A better understanding of the effects of exercise and physical activity on the integrated physiological systems that are involved in the pathophysiology of vascular comorbidities may contribute to the foundations of optimal prescriptions. It may also help to determine the mechanisms responsible for such changes. Data which include multiple populations are also a priority in physiological research as there is a disproportionate prevalence of type 2 diabetes morbidity and mortality across several under-represented groups.
The first goal of this research topic is to determine the influence of exercise and/or physical activity on vascular comorbidity development and/or prognosis in type 2 diabetes. Secondly, this research topic aims to seek specific data that focusses on under-represented populations within the medical literature. We are hopeful that the realization of these goals may assist clinical and exercise practitioners when developing exercise interventions for their patients.
Specific themes of interest include but are not limited to:
• Novel exercise strategies for reducing vascular comorbidities of type 2 diabetes
• Sex, race/ethnicity, and age differences in response to exercise in type 2 diabetes
• Barriers to exercise in people with type 2 diabetes and the impact on vascular comorbidities
• Novel clinical approaches to exercise adherence in type 2 diabetes and the impact on vascular comorbidities
• Comparison of moderate intensity aerobic training to other exercise modalities in reducing vascular comorbidities of type 2 diabetes
All articles accepted by Frontiers are encouraged.